What do patients think about pharma engagement?
Patient engagement has become a cornerstone of the pharmaceutical industry. Leading companies consistently emphasize their dedication to patients and invest in initiatives to build strong connections with the communities that depend on their products. However, patient engagement is still evolving, and companies must continually refine their strategies and demonstrate their long-term commitment to earn the trust of sceptics.
A survey of 92 patients, caregivers, patient advocacy organizations, and other stakeholders has identified both the sources of skepticism towards pharmaceutical companies and the opportunities for the industry to enhance its reputation within these communities.
This brand new patient co-created whitepaper is designed to educate pharmaceutical companies on what patients are advocating for and what they need you to understand.
*Can't access the content? Click here.
This brilliant whitepaper has been created in association with Pharma & Patient USA 2024 (October 15-16, Boston), where 300+ pharma executives and patient advocates will unite to learn first-hand how to drive change that will build a brighter and more inclusive future in healthcare. To find out more, please click the button on the right!
We hope you enjoyed this report!
All the best,
Jacob Byerley
Conference Producer | Pharma & Patient USA 2024
Pharma
Reuters Events
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.